Human immunization with a polymorphic malaria vaccine candidate induced antibodies to conserved epitopes that promote functional antibodies to multiple parasite strains
- Author(s)
- Feng, G; Boyle, MJ; Cross, N; Chan, JA; Reiling, L; Osier, F; Stanisic, D; Mueller, I; Anders, RF; McCarthy, JS; Richards, JS; Beeson, JG;
- Details
- Publication Year 2018-06,Volume 218,Issue #1,Page 35-43
- Journal Title
- Journal of Infectious Diseases
- Publication Type
- Journal Article
- Abstract
- Background: Overcoming antigenic diversity is a key challenge in the development of effective P. falciparum malaria vaccines. Strategies that promote the generation of antibodies targeting conserved epitopes of vaccine antigens may provide protection against diverse parasites strains. Understanding differences between vaccine-induced and naturally-acquired immunity is important to achieving this goal. Methods: We analysed antibodies generated in a phase 1 human vaccine trial, MSP2-C1, which included two allelic forms MSP2, an abundant vaccine antigen on the merozoites surface. Vaccine-induced responses were assessed for functional activity against multiple parasite strains, and cross-reactivity of antibodies was determined using competition ELISA and epitope mapping approaches. Results: Vaccination induced cytophilic antibody responses with strain-transcending opsonic phagocytosis and complement-fixing function. In contrast to antibodies acquired via natural infection, vaccine-induced antibodies were directed towards conserved epitopes at the C-terminus of MSP2, whereas naturally-acquired antibodies mainly targeted polymorphic epitopes. Functional activity of C-terminal targeted antibodies was confirmed using monoclonal antibodies that promoted opsonic phagocytosis against multiple parasite strains. Conclusion: Vaccination generated markedly different responses to polymorphic antigens than naturally-acquired immunity and targeted conserved functional epitopes. Induction of antibodies targeting conserved regions of malaria antigens provides a promising vaccine strategy to overcome antigenic diversity for developing effective malaria vaccines.
- Publisher
- Oxford Academic
- Research Division(s)
- Population Health And Immunity
- PubMed ID
- 29584918
- Link To PubMed Central Version
- http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6904323/
- Publisher's Version
- https://doi.org/10.1093/infdis/jiy170
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2018-04-11 08:53:36
Last Modified: 2020-06-17 09:14:13